Degen Briefing
The investor briefing, restated for the reader who is actually here. Nothing below differs in substance from Terms at a Glance; it is the same instrument described without the assumption that anyone is reading it before buying.
What it is
A token that pays you nothing, backed by a treasury you cannot touch, named after a hormone, issued by a company whose name is one letter from a real one. The formal designation is the 100% Series S Perpetual Stress Preferred Token. It is a joke that clears on chain.
What happens when you buy
You acquire a position. A fee is generated. The fee is converted to tokenized MSTR and added to a treasury, where it stays. You now own a token, and the treasury now owns slightly more than it did. These two facts are unrelated and will remain so.
What you get
Stress, at a rate of 100% per annum, cumulative, paid continuously and without application. This is the only obligation Stragedy has ever met and it meets it in full. There is no second thing.
What you do not get
Dividends. Yield. Interest. Distributions. Redemption. Voting rights. A claim on the treasury. A claim on Strategy Inc., MicroStrategy Incorporated, or anyone else. A price floor. A roadmap. A reason.
The treasury, since you will ask
It is real, it is on chain, and it is published daily at Treasury down to the block. You may verify every unit of it. You may not have any of it. Stragedy reports it in full precisely because reporting costs nothing, distributing would cost something, and a holding you can count but not touch does more work than either.
Why the number is 100%
Because it is a certainty rate and not a dividend rate. It describes the cortisol, which is cumulative, and not the return, which does not exist. A rate of 100% cannot be missed, cannot be cut, and cannot rise. In this one respect the instrument may be described as fully valued.
Where it ranks
The Stragedy capital stack contains one instrument and this is it. It ranks first in a queue of one, for nothing. It does not rank against any security issued by anyone else, and any impression to the contrary is a joke about seniority rather than a statement of it. See Capital Stack.
How this ends
Stragedy publishes no projection, forecast, expected return, or price target, and has none. The most likely outcome is that the price goes to zero and the cortisol rate continues to be paid in full throughout. The second most likely outcome is the same thing more slowly.
Before you do anything
Read the Risk Note. The first risk listed is that the instrument is a joke, and it is listed first because it is the one that matters. Do not commit funds you are unwilling to lose entirely. If the position is already affecting your sleep, Stress Management sets out interventions that will not work.
Figures in this briefing are indicative and should not form the basis of any decision.
Tokenized MSTR is not shares of MicroStrategy Incorporated and confers no shareholder rights, voting rights, or claim on the assets of any issuer.
Stress (STRS) is a token. It is not stock, not a share, and not a security offering. STRS makes no distributions.
Stress is a parody. It is not issued by, endorsed by, sponsored by, or affiliated with Strategy Inc., MicroStrategy Incorporated, or any of their officers.